20 May 2013
Keywords: cytokinetix, cancer, drug, starts, clinical, testing, san
Article | 19 August 2002
San Francisco, USA-based Cytokinetix has started its first clinicalstudy of a novel cancer drug licensed to GlaxoSmithKline, triggering a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 August 2002
© 2013 thepharmaletter.com